Toxicité hépatique de la chimiothérapie du cancer colorectal métastatique : revue de la littérature

The fact that irinotecan may be linked to an increased risk of hepatic failure and postoperative death, which is not the case of oxaliplatine, must be took in consideration in the choice of the preoperative chemotherapy before resection of hepatic metastasis of colorectal cancer.